LGL vs VRTX · P/E 694, rev $1.2M vs P/E 30, rev $3.33B
LGL Group Inc (LGL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
LGL Group Inc (LGL) is a scientific & technical instruments company listed on AMEX.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LGL revenue for 2026-06-30 was $1.2M. Net income was -$353.0K. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. LGL currently screens at market cap $45.5M and trailing P/E 694.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LGL currently screens at market cap $45.5M and trailing P/E 694.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LGL and VRTX stock pages for the full models.
Not investment advice.